Order Entry
United States
ContactUsLinkComponent
Mouse Recombinant IL-36gamma (from E. coli)
Mouse Recombinant IL-36gamma (from E. coli)
  102978-744
 :  Adipogen
 :  
Mouse Recombinant IL-36gamma (from E. coli)
  102978-744
 :  Adipogen
 :  AG-40B-0105-C010
 :  

Some Products May Appear Restricted

To ensure a smooth and speedy checkout, please log in to your account. Some items may show as restricted simply because you're not logged in.

If you do not have an account, you can register using our registration webform (https://www.avantorsciences.com/us/en/login/register)

 

If you're still seeing restrictions after logging in, certain products—like chemicals or medical devices—require additional account verification steps to be able to place an order. Some items may additionally require a specific license or customer documentation;  additional documentation will be requested for these items prior to shipment. 

 

  • Conjugation:
    Unconjugated
  • Protein Function:
    Interleukins
  • Protein/Peptide Type:
    Recombinant
  • Source:
    E. coli
  • Species:
    Mouse
  • Size:
    10 µg
  • Storage Conditions:
    –20 °C
  • Endotoxin Content:
    <0.01EU/µg
  • Biological Activity:
    Induces secretion of IL-6 in BMDCs.
  • Gene ID:
    Q8R460
  • Amino Acid Number:
    13 to 164
  • Protein Synonyms:
    Interleukin-36gamma|Interleukin-1 Family Member 9|IL-1F9
  • Protein/Peptide Name:
    IL-36gamma
  • Purity:
    95%
  • Molecular Weight:
    ~17kDa
  • Endotoxin Level:
    Low
  • Concentration:
    0.1mg/ml after reconstitution.
  • Formulation:
    Lyophilized. Contains PBS.
  • Shipping Temperature:
    -20 °C, Blue Ice
  • Cat. No.:
    102978-744
  • Supplier no.:
    AG40B0105C010

 

 

IL-36alpha (IL-1F6), IL-36beta (IL-1F8) and IL-36gamma (IL-1F9) bind to IL-36R (IL-1Rrp2) and IL-1RAcP, activating similar intracellular signals as IL-1. IL-36Ra inhibits the production of proinflammatory cytokines, including IL-12, IL-1beta, IL-6, TNF-alpha and IL-23 induced by IL-36 in BMDC and CD4 T cells. Skin and dendritic cells are targets of the IL-36 interleukins leading to a Th1 response. These cytokines may represent potential targets for immune-mediated inflammatory conditions or, alternatively, could be used as adjuvants in vaccination.